Last reviewed · How we verify
Placebo filling
A placebo filling serves as an inert control substance in clinical trials to establish baseline efficacy and safety comparisons.
At a glance
| Generic name | Placebo filling |
|---|---|
| Also known as | G5 |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Placebo fillings are inactive formulations used in Phase 3 clinical trials to provide a control arm against which an active investigational drug's efficacy and safety can be measured. They allow researchers to distinguish true drug effects from placebo response and natural disease progression. This is a standard methodological component rather than a therapeutic agent itself.
Approved indications
Common side effects
Key clinical trials
- Effect of Daily Humiome® Post LB Intake on Wellbeing in Older Individuals With Moderate Stress Levels (NA)
- Smart AFO and 5-Azacitidine to Enhance Mobility in Children With Cerebral Palsy (PHASE2)
- Inorganic Nitrate (NaNO3) Prevention of Contrast-Associated Acute Kidney Injury (PHASE2)
- Efficacy of Intraoperative Use of 20% Albumin Combined With Ringer Lactate Versus Ringer Lactate During Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy (NA)
- Assessing the Efficacy of Probiotics in Prevention of NEC in Preterm Babies (NA)
- Impact of the Consumption of Fortified Biscuits on the Iron Status of School-aged Children (NA)
- Enhancing Emotional and Motivational Development to Support Well-being and Retention in Diverse University Students (NA)
- Acetazolamide for Treatment Resistant Schizophrenia (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo filling CI brief — competitive landscape report
- Placebo filling updates RSS · CI watch RSS
- Assistance Publique - Hôpitaux de Paris portfolio CI